Viewing Study NCT02253459


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-02-20 @ 8:26 PM
Study NCT ID: NCT02253459
Status: COMPLETED
Last Update Posted: 2019-04-09
First Post: 2014-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BG01-1323L
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators